159 related articles for article (PubMed ID: 18581722)
21. A strategy of splitting individual high volume cord blood units into two half subunits prior to processing increases the recovery of cells and facilitates ex vivo expansion of the infused haematopoietic progenitor cells in adults.
Papassavas AC; Gioka V; Chatzistamatiou T; Kokkinos T; Anagnostakis I; Gecka G; Redoukas I; Paterakis G; Stavropoulos-Giokas C
Int J Lab Hematol; 2008 Apr; 30(2):124-32. PubMed ID: 18333844
[TBL] [Abstract][Full Text] [Related]
22. Red blood cell depletion with a semiautomated system or hydroxyethyl starch sedimentation for routine cord blood banking: a comparative study.
Solves P; Mirabet V; Planelles D; Blasco I; Perales A; Carbonell-Uberos F; Soler MA; Roig R
Transfusion; 2005 Jun; 45(6):867-73. PubMed ID: 15934983
[TBL] [Abstract][Full Text] [Related]
23. Optimization of microbial screening for cord blood.
Clark P; Trickett A; Chimenti M; Stark D
Transfusion; 2014 Mar; 54(3):550-9. PubMed ID: 23889674
[TBL] [Abstract][Full Text] [Related]
24. Collection and preservation of cord blood for personal use.
Ballen KK; Barker JN; Stewart SK; Greene MF; Lane TA;
Biol Blood Marrow Transplant; 2008 Mar; 14(3):356-63. PubMed ID: 18275904
[TBL] [Abstract][Full Text] [Related]
25. In utero or ex utero cord blood collection: which is better?
Lasky LC; Lane TA; Miller JP; Lindgren B; Patterson HA; Haley NR; Ballen K
Transfusion; 2002 Oct; 42(10):1261-7. PubMed ID: 12423508
[TBL] [Abstract][Full Text] [Related]
26. Establishing a cord blood banking and transplantation program in Mexico: a single institution experience.
Novelo-Garza B; Limon-Flores A; Guerra-Marquez A; Luna-Bautista F; Juan-Shum L; Montero I; Sanchez-Valle E; Vélez-Ruelas MA; Mayani H
Transfusion; 2008 Feb; 48(2):228-36. PubMed ID: 18028272
[TBL] [Abstract][Full Text] [Related]
27. Selection of cord blood unit(s) for transplantation.
Wall DA; Chan KW
Bone Marrow Transplant; 2008 Jul; 42(1):1-7. PubMed ID: 18469873
[TBL] [Abstract][Full Text] [Related]
28. Microbial contamination of hematopoietic progenitor cell products.
Namdaroğlu S; Tekgündüz E; Bozdağ SC; Durgun G; Sarıca A; Demiriz IŞ; Koçubaba S; Iskender G; Kayıkçı O; Altuntaş F
Transfus Apher Sci; 2013 Jun; 48(3):403-6. PubMed ID: 23664302
[TBL] [Abstract][Full Text] [Related]
29. Collection strategies and cryopreservation of umbilical cord blood.
Skoric D; Balint B; Petakov M; Sindjic M; Rodic P
Transfus Med; 2007 Apr; 17(2):107-13. PubMed ID: 17430466
[TBL] [Abstract][Full Text] [Related]
30. Viability does not necessarily reflect the hematopoietic progenitor cell potency of a cord blood unit: results of an interlaboratory exercise.
Brand A; Eichler H; Szczepiorkowski ZM; Hess JR; Kekomaki R; McKenna DH; Pamphilon D; Reems J; Sacher RA; Takahashi TA; van de Watering LM;
Transfusion; 2008 Mar; 48(3):546-9. PubMed ID: 18067495
[TBL] [Abstract][Full Text] [Related]
31. [Cord blood: from bench to bedside].
Bron D; De Bruyn C; Balasse H; Ley P; De Hemptinne D; von Lennep E; Homans C; Marckowicz E; Mathieu P; Deleuse MD; Francotte J; Thomas D; Dorval C; Dejeneffe M; Andrien M; Delforge A
Bull Cancer; 2008 Mar; 95(3):314-9. PubMed ID: 18390411
[TBL] [Abstract][Full Text] [Related]
32. Influence of volume reduction and cryopreservation methodologies on quality of thawed umbilical cord blood units for transplantation.
Solves P; Mirabet V; Planelles D; Carbonell-Uberos F; Roig R
Cryobiology; 2008 Apr; 56(2):152-8. PubMed ID: 18343359
[TBL] [Abstract][Full Text] [Related]
33. Umbilical cord blood transplantation: pros, cons and beyond.
Stanevsky A; Goldstein G; Nagler A
Blood Rev; 2009 Sep; 23(5):199-204. PubMed ID: 19282073
[TBL] [Abstract][Full Text] [Related]
34. Optimizing unrelated donor cord blood transplantation.
Barker JN; Rocha V; Scaradavou A
Biol Blood Marrow Transplant; 2009 Jan; 15(1 Suppl):154-61. PubMed ID: 19147098
[TBL] [Abstract][Full Text] [Related]
35. Microbial contamination of BM products before and after processing: a report of incidence and immediate adverse events in 257 grafts.
Vanneaux V; Foïs E; Robin M; Rea D; de Latour RP; Biscay N; Chantre E; Robert I; Wargnier A; Traineau R; Benbunan M; Marolleau J; Socié G; Larghero J
Cytotherapy; 2007; 9(5):508-13. PubMed ID: 17786612
[TBL] [Abstract][Full Text] [Related]
36. [Banking and indications for cord blood grafts].
Tiberghien P; Chabod J; Deconinck E; Pouthier F
Transfus Clin Biol; 2009 May; 16(2):204-8. PubMed ID: 19443249
[TBL] [Abstract][Full Text] [Related]
37. [A cord blood bank in Tunisia: usefulness and feasibility].
Mellouli F; Fekih J; Ben Hamed L; Sfar R; Rezigua H; Chilli H; Béjaoui M; Mojaat N; Boukef K
Tunis Med; 2008 Jan; 86(1):15-9. PubMed ID: 19472694
[TBL] [Abstract][Full Text] [Related]
38. Use of cost-effectiveness analysis to determine inventory size for a national cord blood bank.
Howard DH; Meltzer D; Kollman C; Maiers M; Logan B; Gragert L; Setterholm M; Horowitz MM
Med Decis Making; 2008; 28(2):243-53. PubMed ID: 18349441
[TBL] [Abstract][Full Text] [Related]
39. [Quality control of cryopreserved cord blood cells for transplantation].
Sato N
Rinsho Byori; 1999 May; Suppl 110():28-33. PubMed ID: 10475028
[TBL] [Abstract][Full Text] [Related]
40. Microbial contamination of hematopoietic progenitor and other regenerative cells used in transplantation and regenerative medicine.
Jacobs MR; Good CE; Fox RM; Roman KP; Lazarus HM
Transfusion; 2013 Nov; 53(11):2690-6. PubMed ID: 23461309
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
